ETF comparison

FHLCvsIBB

Both Healthcare.

Fidelity MSCI Health Care Index ETF · iShares Biotechnology ETF

Holdings overlap

Weighted by ISIN/CUSIP
17.7%

149 positions appear in both funds. Buying equal dollars of FHLC and IBB would leave roughly17.7%of each dollar exposed to the same underlying securities.

FHLC only 82.2%Shared 17.7%IBB only 94.2%
In FHLC only
189 positions
Shared
149 positions
In IBB only
101 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

80composite / 100
Expense ratio
0.084%
Net assets
$3.48B
TTM yield
1.27%
Top-10 conc.
50.6%
IBB

iShares Biotechnology ETF

iShares · Healthcare

70composite / 100
Expense ratio
0.44%
Net assets
$10.47B
TTM yield
0.20%
Top-10 conc.
54.3%

Sub-score comparison

92
Cost
56
83
Tax efficiency
85
80
Liquidity
100
42
Concentration
37
Tracking quality
FHLCsub-scoreIBB

Tracking quality isn't part of the composite — seewhat we don't scorefor why.

Cost difference

FHLC is 36 bps cheaper than IBB. On a $100,000 position that's about $356/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with FHLC vs IBB.

Top shared holdings

149 shared in total
#HoldingIn FHLCIn IBBOverlap
1Amgen Inc3.01%7.83%3.01%
2Gilead Sciences Inc2.62%6.84%2.62%
3Vertex Pharmaceuticals Inc1.75%8.08%1.75%
4Regeneron Pharmaceuticals Inc1.18%4.91%1.18%
5Alnylam Pharmaceuticals Inc0.66%3.12%0.66%
6Insmed Inc0.47%1.78%0.47%
7Biogen Inc0.45%2.47%0.45%
8Natera Inc0.44%2.89%0.44%
9United Therapeutics Corp0.38%1.73%0.38%
10Revolution Medicines Inc0.38%2.78%0.38%
11Illumina Inc0.31%2.07%0.31%
12Moderna Inc0.26%1.98%0.26%

Only in FHLC

189 total
  • Eli Lilly & Co12.13%
  • Johnson & Johnson8.94%
  • AbbVie Inc6.03%
  • UnitedHealth Group Inc5.42%
  • Merck & Co Inc4.38%
  • Thermo Fisher Scientific Inc2.91%
  • Intuitive Surgical Inc2.62%
  • Abbott Laboratories2.55%
  • Pfizer Inc2.45%
  • Bristol-Myers Squibb Co1.99%

Only in IBB

101 total
  • BlackRock Funds III11.66%
  • Argenx SE3.76%
  • BeOne Medicines Ltd.1.77%
  • Ascendis Pharma A/S1.29%
  • Genmab A/S1.12%
  • Abivax SA0.67%
  • BioNTech SE0.66%
  • BlackRock Funds III0.38%
  • Legend Biotech Corp.0.33%
  • Structure Therapeutics, Inc.0.24%

Open FHLC or IBB at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.